Some studies suggest that elevated β-catenin levels in breast cancer could be partially due to loss of Cadherin 1 (CDH1), a frequently observed feature in advanced and invasive tumors (Prasad et al., 2008). This evidence concerns the gene CDH1 and breast carcinoma.